I don't know if that works I think best is talking about it with Europeans like on here and slowly getting people to change their mind it That's how movements start And movements change governments
POLICY
-
Europe needs business-friendly regulatory reforms for startups
By
–
ChatGPT 4:
Europe needs a business-friendly makeover Current bureaucracy, high taxes, strict labor laws, and heavy regulations stifle startups, favoring big companies Simple solution: Implement revenue regulation cutoffs to let small businesses grow without immediate regulatory -
Improving Europe’s Business Environment for Entrepreneurs
By
–
Some things here in my list that Europe could improve to help make it a better business environment for entrepreneurs: (P.S. I'm not Ultra IQ so probably some errors in here but you get the rough idea, it's not rly about the details so much as the general tendency here that's
-
Dutch Government Fights ASML Relocation Attempt
By
–
Yeah ASML is going great for NL, even they are trying to GTFO https://
euronews.com/business/2024/
03/07/dutch-government-tries-to-stop-asml-from-moving-out
… -
Regulation Alone Cannot Drive AI Progress Forward
By
–
Thanks for this. Especially good to see after having just watched a doomer/decel TED talk about how regulation is our only hope.
-

Cerebras Powers NSF National AI Research Resource Pilot
By
–
Cerebras Systems is proud to be a key technology provider to the @NSF
's National Artificial Intelligence Research Resource (NAIRR) Pilot. Applications that support AI research will be granted system time on Cerebras AI Accelerators. We are honored to support the United -
Generative AI: French Split Between Optimism and Concerns
By
–
[#Article] Gen AI: French Mixed Between Enthusiasm and Worry According to BCG Report https://actuia.com/actualite/gen-ai-les-francais-mitiges-entre-enthousiasme-et-inquietude-selon-un-rapport-du-boston-consulting-group/
… #AI #artificialintelligence -
FDA Lags Behind FTC on AI Hype in Pharma
By
–
Latest Mystery AI Hype Theater 3000 newsletter, on AI hype infecting a key player in the pharmaceutical sector. Wouldn't it be great if the FDA were as on top of the impacts of AI hype as the FTC?